Pharmafile Logo
Pharmafocus logo
Advanced Search

life sciences

Showing 15 posts of 91 posts found.

scotland

Scotland’s life sciences sector on track to break $8 billion by 2025

February 25, 2020
Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma

A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …

News
dave_tudor

GSK veteran Dave Tudor joins MMIC in Scotland

November 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Scotland, dave tudor, life sciences, manufacturing

GlaxoSmithKline veteran, Dave Tudor, is set to take on the role of Managing Director of the Medicines Manufacturing Innovation Centre …

Appointment
boardroom

The value of measuring biotech Board performance

October 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RSA Group, biotech, board, life sciences, opinion, pharma

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …

Feature
nicolas_raymond

The measurement underpinning government goals for UK life sciences

January 22, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …

Feature
houses-of-parliament-1055056_960_720

UK government unveils pharma research HQ coup

November 27, 2017
Medical Communications, Sales and Marketing MSD, biotech, drugs, life sciences, pharma, pharmaceutical

The UK government’s Autumn Budget struck a gloomy note for the economy, with figures pointing towards low productivity and the …

News
shutterstock_114306559

Could the new EU Medical Devices Regulation put the UK MedTech industry in peril?

September 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medical devices, medical technology, medtech, medtech regulation, pharma, pharmaceutical

Gill Jennings and Every’s Fiona Stevens discusses recent developments in medical devices regulation and the subsequent impact on IP and …

Feature
alzheimers-749616_960_720

Alzheimer’s disease: Fighting back against a growing threat

September 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's UK, dementia, life sciences, pharma

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …

Feature
mr058666-web

Merck KGaA commits to continued partnership with Ugandan Government

September 5, 2017
Manufacturing and Production, Medical Communications Merck, infertility, life sciences, pharma, pharmaceuticals, uganda

Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

News
astrazeneca_building_white

NICE rejects AstraZeneca’s breast cancer drug Faslodex

September 1, 2017
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

News
virginia-7592

Has Trump’s power over pharma come to an end after Charlottesville?

August 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …

Feature
2000px-flag_of_south_korea

J&J offers $134,000 grant to find the best start-up in South Korea

August 31, 2017
Research and Development J&J. pharma, Johnson & Johnson, drugs, life sciences, medicine, pharmaceutical, south korea

Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …

News
brexit_flag_0

UK’s post-Brexit strategy looks to life sciences industry

August 30, 2017
Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

News
ecstasy_monogram

FDA fast-tracks recreational drug MDMA for treatment of PTSD

August 30, 2017
Research and Development, Sales and Marketing FDA, MDMA, PTSD, life sciences, pharma, pharmaceuticals

In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …

News
pharmafocus_september_2017_cover

The September 2017 issue of Pharmafocus is now live!

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma

The September edition of Pharmafocus is now available – click here to read online.

News

Latest content

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023